Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential

Last update: Oct 29, 2026

Details

Location: EU 27
Contracting Authority: Horizon Europe (2021 - 2027)
Contracting Authority Type: Development Institution
Status: Open
Budget: EUR 44,200,000
Award ceiling: 11,000,000
Award floor: 9,000,000
Sector: Health, Research & Innovation
Eligible applicants: Unrestricted / Unspecified
Eligible nationalities: Afghanistan, Albania, Algeria, Angola, Argentina, Armenia, Aruba, Austria, Azerbaijan, Bangladesh, Belarus, Belgium, Belize, Benin, Bhutan, Bolivia, Bosnia and Herzegovina, Bulgaria, Burkina Faso, Burundi, Cambodia, Cameroon, Canada, Cape Verde, Central African Republic, Chad, Colombia, Comoros, Congo, Costa Rica, Cote d'Ivoire, Croatia, Cuba, Curaçao, Cyprus, Czech Republic, Dem. Rep. Congo, Denmark, Djibouti, Dominica, Commonwealth of, Dominican Republic, Ecuador, Egypt, El Salvador, Equatorial Guinea, Eritrea, Estonia, Eswatini (Swaziland), Ethiopia, Faroe Islands, Fiji, Finland, France, French Polynesia, French Southern Territory, Gabon, Gambia, Georgia, Germany, Ghana, Greece, Greenland, Grenada, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Honduras, Hungary, Iceland, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Jamaica, Jordan, Kazakhstan, Kenya, Kiribati, Kosovo, Kyrgyzstan, Laos, Latvia, Lebanon, Lesotho, Liberia, Libya, Lithuania, Luxembourg, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Marshall Islands, Mauritania, Mauritius, Micronesia, Moldova, Mongolia, Montenegro, Morocco, Mozambique, Myanmar, Namibia, Nepal, Netherlands, New Caledonia, New Zealand, Nicaragua, Niger, Nigeria, Niue, North Korea, North Macedonia, Norway, Pakistan, Palau, Palestine / West Bank & Gaza, Papua New Guinea, Paraguay, Peru, Philippines, Poland, Portugal, Romania, Rwanda, Saint Lucia, Saint Vincent and the Grenadines, Samoa, Sao Tome and Principe, Senegal, Serbia, Sierra Leone, Sint Maarten, Slovakia, Slovenia, Solomon Islands, Somalia, South Africa, South Korea, South Sudan, Spain, Sri Lanka, St. Pierre and Miquelon, Sudan, Suriname, Sweden, Switzerland, Syria, Tajikistan, Tanzania, Thailand, Timor-Leste, Togo, Tonga, Tunisia, Türkiye, Turkmenistan, Tuvalu, Uganda, UK, Ukraine, Uzbekistan, Vanuatu, Venezuela, Vietnam, Wallis and Futuna, Yemen, Zambia, Zimbabwe
Date posted: Dec 12, 2025

Quick Summary

Objectives: 

Objectives

  • Purpose: Develop novel small-molecule antivirals for pathogens with epidemic potential, improving preparedness for future outbreak response and expanding option...
Eligibility criteria: 
  • Eligible applicants: Any legal entity may participate, including entities from non-EU/non-associated countries and international organisations, subject to the call rules.
  • Geographic and legal eligibility: Legal entities established in the United States are eligible to receive Union funding. Legal entities established in China are not eligible to participate in this Research and Innovation Action under this destination. Entities established in Russia, Belarus, or non-government-controlled territories of Ukr...
Share

Similar grants

By Locations
Funding Agency: NGO
Status: open
Location: Ireland, UK
Funding Agency: Government
Status: open
Location: France
By Sectors
Funding Agency: Government
Status: open
Location: Norway
Funding Agency: NPO
Status: open
Location: Worldwide